EXROF(EXROF)
EXROF
No analyst ratings available
No analyst price targets available for EXROF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $62M | $163M |
| Low | $62M | $163M |
| High | $62M | $163M |
| EBITDA Avg | $-12M | $-33M |
| Low | $-12M | $-33M |
| High | $-12M | $-33M |
| EBIT Avg | $-12M | $-33M |
| Low | $-12M | $-33M |
| High | $-12M | $-33M |
| Net Income Avg | $-26M | $-44M |
| Low | $-26M | $-44M |
| High | $-26M | $-44M |
| EPS Avg | $-0.06 | $-0.10 |
| Low | $-0.06 | $-0.10 |
| High | $-0.06 | $-0.10 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $38M | $48M | $38M | $40M | $42M | $43M |
| Low | $38M | $48M | $38M | $40M | $42M | $43M |
| High | $38M | $48M | $38M | $40M | $42M | $43M |
| EBITDA Avg | $-8M | $-10M | $-8M | $-8M | $-8M | $-9M |
| Low | $-8M | $-10M | $-8M | $-8M | $-8M | $-9M |
| High | $-8M | $-10M | $-8M | $-8M | $-8M | $-9M |
| EBIT Avg | $-8M | $-10M | $-8M | $-8M | $-8M | $-9M |
| Low | $-8M | $-10M | $-8M | $-8M | $-8M | $-9M |
| High | $-8M | $-10M | $-8M | $-8M | $-8M | $-9M |
| Net Income Avg | $-14M | $-6M | — | — | — | — |
| Low | $-14M | $-6M | — | — | — | — |
| High | $-14M | $-6M | — | — | — | — |
| EPS Avg | $-0.02 | $-0.01 | — | — | — | — |
| Low | $-0.02 | $-0.01 | — | — | — | — |
| High | $-0.02 | $-0.01 | — | — | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — | 1 / — |